European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I S Krege, J Beyer, R Souchon, P Albers, W Albrecht, F Algaba, M Bamberg, ... European urology 53 (3), 478-496, 2008 | 764 | 2008 |
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) HJ Schmoll, R Souchon, S Krege, P Albers, J Beyer, C Kollmannsberger, ... Annals of Oncology 15 (9), 1377-1399, 2004 | 662 | 2004 |
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis C Bokemeyer, CR Nichols, JP Droz, HJ Schmoll, A Horwich, A Gerl, ... Journal of Clinical Oncology 20 (7), 1864-1873, 2002 | 582 | 2002 |
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Beyer, A Kramar, R Mandanas, W Linkesch, A Greinix, JP Droz, JL Pico, ... Journal of clinical oncology 14 (10), 2638-2645, 1996 | 405 | 1996 |
Hematopoietic rescue Beyer Journal of clinical oncology 13, 1328, 1995 | 342 | 1995 |
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer, J Busch, ... Annals of oncology 24 (4), 878-888, 2013 | 321 | 2013 |
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up J Oldenburg, SD Fosså, J Nuver, A Heidenreich, HJ Schmoll, ... Annals of Oncology 24, vi125-vi132, 2013 | 320 | 2013 |
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas, ... Annals of oncology 29 (8), 1658-1686, 2018 | 300 | 2018 |
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German … J Schetelig, C Thiede, M Bornhauser, R Schwerdtfeger, M Kiehl, J Beyer, ... Journal of Clinical Oncology 21 (14), 2747-2753, 2003 | 297 | 2003 |
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy International Prognostic Factors Study Group Journal of Clinical Oncology 28 (33), 4906-4911, 2010 | 289 | 2010 |
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database A Lorch, C Bascoul-Mollevi, A Kramar, L Einhorn, A Necchi, C Massard, ... J Clin Oncol 29 (16), 2178-84, 2011 | 252 | 2011 |
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. C Kollmannsberger, J Beyer, JP Droz, A Harstrick, JT Hartmann, P Biron, ... Journal of Clinical Oncology 16 (10), 3386-3391, 1998 | 237 | 1998 |
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised … G Attard, L Murphy, NW Clarke, W Cross, RJ Jones, CC Parker, ... The lancet 399 (10323), 447-460, 2022 | 223 | 2022 |
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors JT Hartmann, CR Nichols, JP Droz, A Horwich, A Gerl, SD Fossa, J Beyer, ... Journal of the National Cancer Institute 92 (1), 54-61, 2000 | 223 | 2000 |
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial S Schwartz, G Behre, V Heinemann, H Wandt, E Schilling, M Arning, ... Blood, The Journal of the American Society of Hematology 93 (11), 3654-3661, 1999 | 216 | 1999 |
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study … C Kollmannsberger, J Beyer, R Liersch, P Schöffski, B Metzner, ... Journal of clinical oncology 22 (1), 108-114, 2004 | 196 | 2004 |
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic … HJ Schmoll, C Kollmannsberger, B Metzner, JT Hartmann, N Schleucher, ... Journal of clinical oncology 21 (22), 4083-4091, 2003 | 177 | 2003 |
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome C Bokemeyer, JP Droz, A Horwich, A Gerl, SD Fossa, J Beyer, J Pont, ... Cancer 91 (7), 1394-1401, 2001 | 175 | 2001 |
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with … O Rick, C Bokemeyer, J Beyer, JT Hartmann, N Schwella, D Kingreen, ... Journal of clinical oncology 19 (1), 81-88, 2001 | 174 | 2001 |
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest … HG Sayer, M Kröger, J Beyer, M Kiehl, SA Klein, K Schaefer-Eckart, ... Bone marrow transplantation 31 (12), 1089-1095, 2003 | 168 | 2003 |